Orrick represented Kineta on the deal.Kineta, Inc., a clinical-stage biotechnology company focused on developing novel immunotherapies in oncology that address cancer immune resistance, has entered into…
TuHURA Biosciences’ Acquisition of Kineta
Orrick represented Kineta on the deal.Kineta, Inc., a clinical-stage biotechnology company focused on developing novel immunotherapies in oncology that address cancer immune resistance, has entered into…